help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, D.
Right arrow Articles by Cone, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, D.
Right arrow Articles by Cone, R. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ASPARTIC ACID
*(L)-HISTIDINE
*(L)-PROLINE
*GLUTAMIC ACID HYDROCHLORIDE
*L-LYSINE
Molecular Endocrinology 12 (4): 592-604
Copyright © 1998 by The Endocrine Society

A Ligand-Mimetic Model for Constitutive Activation of the Melanocortin-1 Receptor

Dongsi Lu, Dag Inge Vage and Roger D. Cone

Vollum Institute (D.L., R.D.C.) Oregon Health Sciences University Portland, Oregon 97201
Department of Animal Science (D.I.V.) Agricultural University of Norway N-1432 As, Norway

Dark coat color in the mouse and fox results from constitutively activated melanocortin-1 receptors. Receptor mutations in the mouse (E92K, L98P), cow (L99P), fox (C125R), and sheep (D119N) cluster near the membrane/extracellular junctions of the second and third transmembrane domains, an acidic domain that is the likely site of electrostatic interaction with an arginine residue in the ligand, {alpha}-MSH. For transmembrane residues E92, D119, and C125, conversion to a basic residue is required for constitutive activation. Unlike constitutively activating mutations in many G protein-coupled receptors that increase agonist efficacy and affinity, these MC1-R mutations have the opposite effect. Therefore, these mutations do not activate the receptor by directly disrupting intramolecular constraints on formation of the active high-affinity state, R*, but do so indirectly by mimicking ligand binding.




This article has been cited by other articles:


Home page
Mol Biol EvolHome page
T. Haitina, A. Ringholm, J. Kelly, N. I. Mundy, and H. B. Schioth
High Diversity in Functional Properties of Melanocortin 1 Receptor (MC1R) in Divergent Primate Species Is More Strongly Associated with Phylogeny than Coat Color
Mol. Biol. Evol., September 1, 2007; 24(9): 2001 - 2008.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva
The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure
Physiol Rev, April 1, 2007; 87(2): 565 - 592.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. D. Cone
Studies on the Physiological Functions of the Melanocortin System
Endocr. Rev., December 1, 2006; 27(7): 736 - 749.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. R. HOLDER and C. HASKELL-LUEVANO
Melanocortin Tetrapeptides Modified at the N-Terminus, His, Phe, Arg, and Trp Positions
Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 36 - 48.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. SRINIVASAN, C. VAISSE, and B. R. CONKLIN
Engineering the Melanocortin-4 Receptor to Control Gs Signaling in Vivo
Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 225 - 232.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
H. KLUNGLAND and D. I. VAGE
Pigmentary Switches in Domestic Animal Species
Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 331 - 338.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. M. Swords, A. Baig, D. M. Malchoff, C. D. Malchoff, M. O. Thorner, P. J. King, L. Hunyady, and A. J. L. Clark
Impaired Desensitization of a Mutant Adrenocorticotropin Receptor Associated with Apparent Constitutive Activity
Mol. Endocrinol., December 1, 2002; 16(12): 2746 - 2753.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. H. Ho, D. Du, and M. C. Gershengorn
The N Terminus of Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Is Necessary for High Affinity Chemokine Binding but Not for Constitutive Activity
J. Biol. Chem., October 29, 1999; 274(44): 31327 - 31332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Silvente-Poirot, C. Escrieut, C. Gales, J.-A. Fehrentz, A. Escherich, S. A. Wank, J. Martinez, L. Moroder, B. Maigret, M. Bouisson, et al.
Evidence for a Direct Interaction between the Penultimate Aspartic Acid of Cholecystokinin and Histidine 207, Located in the Second Extracellular Loop of the Cholecystokinin B Receptor
J. Biol. Chem., August 13, 1999; 274(33): 23191 - 23197.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society